Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/05/2010WO2010040843A3 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds
08/05/2010WO2010039260A3 Spiperone derivatives and methods of treating disorders
08/05/2010WO2010033771A3 Modulators of hsp70/dnak function and methods of use thereof
08/05/2010WO2010033196A3 Simplified one-pot synthesis of [18f]sfb for radiolabeling
08/05/2010WO2010031708A3 Ortho-aminoanilides for the treatment of cancer
08/05/2010WO2010031056A3 Methods and compositions for modulating ire1, src, and abl activity
08/05/2010WO2010030132A9 Purification method for adefovir dipivoxil
08/05/2010WO2010028093A3 Use of a truncated elf-5a1 polynucleotide to induce apoptosis in cancer cells
08/05/2010WO2010025380A3 Analysis of hcv genotypes
08/05/2010WO2010023512A8 Novel vanilloid receptor modulators, process for their preparation and pharmaceutical compositions containing them
08/05/2010WO2010017570A3 Pharmaceutical form comprising tetrahydrobiopterin
08/05/2010WO2010014784A3 Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
08/05/2010WO2010012459A3 A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
08/05/2010WO2010001169A3 Chemical compounds 251
08/05/2010WO2009156837A3 Amorphous form of a 3-pyrrole substituted 2-indolinone malate salt
08/05/2010WO2009152228A9 Use of the combination of phy906 and a tyrosine kinase inhibitor as a cancer treatment regimen
08/05/2010WO2009142827A3 Compounds and methods for the treatment of viral infection
08/05/2010WO2009130204A3 Improved formulations for poorly permeable active pharmaceutical ingredients
08/05/2010WO2009100872A8 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/05/2010WO2009052617A9 Treatment regime for proliferative disorders
08/05/2010WO2007048097A3 Anbrosteeone derivatives and method of use thereof
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199362 Wnt ligands involved in blood-brain barrier development and uses therefor
08/05/2010US20100199361 Role of Proteoglycans in Drug Dependence
08/05/2010US20100198344 Sustained drug-releasing stent
08/05/2010US20100197953 Levodopa prodrugs, and compositions and uses thereof
08/05/2010US20100197948 Inhibitors of yeast filamentous growth and method of their manufacture
08/05/2010US20100197941 Process for the production of atorvastatin calcium in amorphous form
08/05/2010US20100197922 Azabicycloalkane compounds
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197913 Non-nucleotide composition for inhibiting platelet aggregation
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197804 Pharmaceutical compositions comprising terbinafine
08/05/2010US20100197803 Method for obtaining a sequoyitol-containing extract from a plant of the genus of trifolium, leguminosae or ginkoaceae and uses thereof
08/05/2010US20100197802 Skin dressings
08/05/2010US20100197801 Volatile Distillate By-Product of Mint Oil That Promotes Absorption and/or Bioavailability of Compounds of Bio-Medical and Nutritional Interest
08/05/2010US20100197800 Treatment and/or Prevention of Presbycusis by Modulation of Metabotropic Glutamate Receptor 7
08/05/2010US20100197799 Hydroxylamine derivatives
08/05/2010US20100197798 Abuse-resistant amphetamine prodrugs
08/05/2010US20100197797 Methods of managing fibromyalgia using milnacipran
08/05/2010US20100197796 Use of milnacipran or salt, excludes administering phenylalanine, tyrosine, or tryptophan
08/05/2010US20100197795 Transdermal compositions
08/05/2010US20100197793 Solid state forms of aliskiren compounds
08/05/2010US20100197792 1-Amino-Alkylcyclohexane derivatives for the treatment of inflammatory skin diseases
08/05/2010US20100197791 Pharmaceuticals for transdermal use on animals
08/05/2010US20100197790 Container for pharmaceutical use for the quantitative release of a single dose for oral administration of t3 and t4 thyroid hormones in solution
08/05/2010US20100197789 Anti-obesity agent and use thereof
08/05/2010US20100197788 Preventive or therapeutic agent for disease caused by decrease in lacrimal fluid
08/05/2010US20100197787 Composition for Prevention of Hypoglycemic Condition
08/05/2010US20100197785 Omega-3 fatty acid fortified composition
08/05/2010US20100197784 Novel curcumin analogues and uses thereof
08/05/2010US20100197783 Radiation Protection Using Single Wall Carbon Nanotube Derivatives
08/05/2010US20100197782 Therapeutic agent for virus-associated malignancy
08/05/2010US20100197781 Anti-Malarial Compound Isolated from Gomphostema Niveum
08/05/2010US20100197780 Compounds extracted from palm oil mill effluent for the treatment of cancer, compositions thereof and methods therewith
08/05/2010US20100197779 Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
08/05/2010US20100197778 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases
08/05/2010US20100197777 Synergistic combination of analgesic compounds
08/05/2010US20100197776 Direct dissolution of docetaxel in a solvent in polysorbate 80
08/05/2010US20100197775 Methods and compositions for treating & diagnosing mood disorders, schizophrenia, and neuro-psychiatric disorders
08/05/2010US20100197774 MicroRNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS
08/05/2010US20100197773 Compositions and methods for inhibiting expression of ptp1b genes
08/05/2010US20100197772 Tissue-Specific MicroRNAs and Compositions and Uses Thereof
08/05/2010US20100197771 Influenza virus vaccine composition and methods of use
08/05/2010US20100197770 Methods for Determining Heptocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells
08/05/2010US20100197769 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd)
08/05/2010US20100197768 Methods and compositions related to the structure and function of apobec3g
08/05/2010US20100197767 Nucleic acid construct systems capable of daignosing or treating a cell state
08/05/2010US20100197766 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and Uses Thereof in the Treatment of Cancer
08/05/2010US20100197765 Method for promoting the expression of p53, and p53 expression promoter for use in the method
08/05/2010US20100197764 Antisense modulation of acyl coa cholesterol acyltransferase-2 expression
08/05/2010US20100197763 RNA Interference Mediated Inhibition of Cyclic Nucleotide Type 4 Phosphodiesterase (PDE4B) Gene Expression Using Short Interfering Nucleic Acid (siNA)
08/05/2010US20100197762 Antisense compounds
08/05/2010US20100197761 Fused cyclic compounds
08/05/2010US20100197760 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
08/05/2010US20100197759 Administration of dithiolane compounds for photoprotecting the skin
08/05/2010US20100197758 Ischemia/reperfusion protection compositions and methods of using
08/05/2010US20100197757 Oxindoles as kinase inhibitors
08/05/2010US20100197756 Indole-3-Sulphur Derivatives
08/05/2010US20100197755 Hydrazone modulators of cannabinoid receptors
08/05/2010US20100197754 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
08/05/2010US20100197753 Benzamides Useful as S1P Receptor Modulators
08/05/2010US20100197752 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
08/05/2010US20100197751 Compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing
08/05/2010US20100197750 Preservation Of Ergothioneine
08/05/2010US20100197749 Chemical compounds
08/05/2010US20100197746 Synthesis of epothilones, intermediates thereto and analogues thereof
08/05/2010US20100197745 Gamma-glutamyl transpeptidase inhibitors and methods of use
08/05/2010US20100197744 Organic Compounds
08/05/2010US20100197742 New formulations and use thereof
08/05/2010US20100197740 Method of Screening Compounds Having Anti-Amyloid Properties
08/05/2010US20100197736 Cetp activity inhibitors
08/05/2010US20100197735 Novel phenylurea inhibitors of the enzyme soat-1 and pharmaceutical/cosmetic compositions comprised thereof
08/05/2010US20100197734 Pleuromutilin derivatives and their use as antimicrobials
08/05/2010US20100197733 Pyrrolidines and piperidines as orexin receptor antagonists
08/05/2010US20100197732 Repaglinide Substantially Free of Dimer Impurity
08/05/2010US20100197731 kind of piperphentonamine hydrochloride lyophilized powder for injection and preparation and use thereof
08/05/2010US20100197730 Methods for treating anxiety
1 ... 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 2165 2166 2167 ... 7860